Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Rose-Nussbaumer

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
JAMA Ophthalmology|January 13, 2022
Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical TrialsN Venkatesh Prajna, Prajna Lalitha, Tiruvengada Krishnan, et al.
Ophthalmic Epidemiology|April 26, 2019
Repeatability and Reproducibility of Slit Lamp, Optical Coherence Tomography, and Scheimpflug Measurements of Corneal ScarsManoranjan Das, Shivali A Menda, Arun K Panigrahi, et al.
American Journal of Ophthalmology|February 14, 2018
The Significance of Repeat Cultures in the Treatment of Severe Fungal KeratitisKathryn J Ray, N Venkatesh Prajna, Prajna Lalitha, et al.
JAMA Ophthalmology|August 18, 2017
Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial IIN Venkatesh Prajna, Tiruvengada Krishnan, Revathi Rajaraman, et al.
Clinical & Experimental Ophthalmology|June 20, 2013
Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mLJennifer Rose-Nussbaumer, Debra A Goldstein, Jennifer E Thorne, et al.
JAMA Ophthalmology|June 25, 2026
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction: Follow-Up of a Randomized Clinical TrialN Venkatesh Prajna, Alec Bernard, Lalitha Prajna, et al.
JAMA Ophthalmology|March 13, 2015
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical TrialJennifer Rose-Nussbaumer, N Venkatesh Prajna, K Tiruvengada Krishnan, et al.
JAMA Ophthalmology|April 21, 2017
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial IIN Venkatesh Prajna, Tiruvengada Krishnan, Revathi Rajaraman, et al.
Indian Journal of Ophthalmology|March 8, 2024
Locality is the strongest predictor of expert performance in image-based differentiation of bacterial and fungal corneal ulcers from IndiaChristopher R Rosenberg, Venkatesh Prajna, Muthiah K Srinivasan, et al.
The British Journal of Ophthalmology|November 5, 2015
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazoleJennifer Rose-Nussbaumer, N Venkatesh Prajna, Tiruvengada Krishnan, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
JAMA Ophthalmology|January 13, 2022
Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical TrialsN Venkatesh Prajna, Prajna Lalitha, Tiruvengada Krishnan, et al.
Ophthalmic Epidemiology|April 26, 2019
Repeatability and Reproducibility of Slit Lamp, Optical Coherence Tomography, and Scheimpflug Measurements of Corneal ScarsManoranjan Das, Shivali A Menda, Arun K Panigrahi, et al.
American Journal of Ophthalmology|February 14, 2018
The Significance of Repeat Cultures in the Treatment of Severe Fungal KeratitisKathryn J Ray, N Venkatesh Prajna, Prajna Lalitha, et al.
JAMA Ophthalmology|August 18, 2017
Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial IIN Venkatesh Prajna, Tiruvengada Krishnan, Revathi Rajaraman, et al.
Clinical & Experimental Ophthalmology|June 20, 2013
Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mLJennifer Rose-Nussbaumer, Debra A Goldstein, Jennifer E Thorne, et al.
JAMA Ophthalmology|June 25, 2026
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction: Follow-Up of a Randomized Clinical TrialN Venkatesh Prajna, Alec Bernard, Lalitha Prajna, et al.
JAMA Ophthalmology|March 13, 2015
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical TrialJennifer Rose-Nussbaumer, N Venkatesh Prajna, K Tiruvengada Krishnan, et al.
JAMA Ophthalmology|April 21, 2017
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial IIN Venkatesh Prajna, Tiruvengada Krishnan, Revathi Rajaraman, et al.
Indian Journal of Ophthalmology|March 8, 2024
Locality is the strongest predictor of expert performance in image-based differentiation of bacterial and fungal corneal ulcers from IndiaChristopher R Rosenberg, Venkatesh Prajna, Muthiah K Srinivasan, et al.
The British Journal of Ophthalmology|November 5, 2015
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazoleJennifer Rose-Nussbaumer, N Venkatesh Prajna, Tiruvengada Krishnan, et al.
Pageof 8